周邊神經損傷市場規模、佔有率和成長分析：按損傷類型、按產品、按治療、按手術、按應用、按地區 - 行業預測，2024-2031 年

2022年周邊神經損傷市場規模預計為14.3億美元，預測期內（2024-2031年）複合年成長率為7.65%，從2023年的15.4億美元增至2031年的27.8億美元。 10,000,000 美元。

近年來，由於創傷相關事故的增加、神經修復技術的進步以及人口老化等因素，周邊神經損傷市場取得了顯著的進展。手術方法和生物材料的改進顯著改善了患者的預後，並推動了市場的擴張。神經刺激和神經調節療法也使治療選擇多樣化。學術界、醫療公司和研究機構之間的合作正在推動創新療法的發展。然而，治療費用高、報銷有限等挑戰仍然存在。隨著對有效解決方案的需求增加，市場相關人員必須克服這些障礙，使該行業成為醫療保健領域充滿活力的行業。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 成功的關鍵因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

周邊神經損傷市場：按損傷類型

• 市場概況
• 創傷
• 壓力損傷
• 手術損傷

周邊神經損傷市場：依產品

• 市場概況
• 神經導管
• 神經保護器
• 神經連接器
• 神經包紮

周邊神經損傷市場：依治療分類

• 市場概況
• 手術治療
• 物理治療
• 藥物治療

周邊神經損傷市場：透過手術

• 市場概況
• 直接神經修復
• 神經移植
• 幹細胞療法

周邊神經損傷市場：依應用分類

• 市場概況
• 下肢
• 上肢

周邊神經損傷市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（United States）
• Abbott Laboratories（United States）
• Stryker Corporation（United States）
• Baxter International Inc.（United States）
• Integra LifeSciences Holdings Corporation（United States）
• Axogen Corporation（United States）
• NeuroPace, Inc.（United States）
• Nuvectra Corporation（United States）
• OrthoPediatrics Corp.（United States）
• Polyganics BV（Netherlands）
• Zimmer Biomet Holdings, Inc.（United States）
• Smith & Nephew plc（United Kingdom）
• NeuroMetrix, Inc.（United States）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Natus Medical Incorporated（United States）
• LivaNova plc（United Kingdom）
• AxoGen Corporation（United States）
• Bioventus LLC（United States）

Peripheral Nerve Injuries Market size was valued at USD 1.43 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 2.78 billion by 2031, at a CAGR of 7.65% during the forecast period (2024-2031).

Recent years have witnessed significant advancements in the peripheral nerve injuries market, fueled by factors such as rising trauma-related incidents, advancements in nerve repair technologies, and an aging population. Improvements in surgical methods and biomaterials have notably enhanced patient outcomes, stimulating market expansion. Neurostimulation and neuromodulation therapies have also diversified treatment options. Collaborations among academia, medical firms, and research entities have spurred innovative therapy development. Nevertheless, challenges like high treatment costs and limited reimbursements persist. Market stakeholders must navigate these hurdles amidst growing demand for effective solutions, making this sector dynamic within healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Nerve Injuries Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Nerve Injuries Market Segmental Analysis

The peripheral nerve injuries market can be segmented based on injury type, product, treatment, surgery, application, and region. Based on injury type, the market is segmented into traumatic injuries, compression injuries, and surgical injuries. Based on product, the market is segmented into nerve conduit, nerve protector, nerve connector, and nerve wraps. Based on treatment, the market is segmented into surgical interventions, physical therapy, and pharmaceutical interventions. Based on surgery, the market is segmented into direct nerve repair, nerve grafting, and stem cell therapy. Based on application, the market is segmented into lower extremities and upper extremities. Geographically, the market is divided into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Peripheral Nerve Injuries Market

Technological advancements, including the development of innovative wound care products and minimally invasive surgical techniques, significantly drive growth in the Peripheral Nerve Injuries Market. These innovations enhance the effectiveness and efficiency of burn treatments, resulting in improved patient outcomes and shorter recovery times.

Restraints in the Peripheral Nerve Injuries Market

The treatment expenses associated with peripheral nerve injuries, encompassing surgeries, rehabilitation, and ongoing care, can impose significant financial burdens. These high costs often restrict access to care for many patients and hinder market expansion. Furthermore, despite advancements in medical technology, treatment options for peripheral nerve injuries remain limited. Nerve regeneration is intricate, and achieving full recovery remains elusive, posing considerable challenges for both patients and healthcare providers alike.

Market Trends of the Peripheral Nerve Injuries Market

Technological advancements in nerve repair are a key trend in the peripheral nerve injuries market, marked by ongoing developments in nerve regeneration technologies. Researchers and medical device firms are innovating with nerve conduits, neurostimulation devices, and bioengineered materials to enhance treatment outcomes. These advancements aim to accelerate nerve regeneration, shorten recovery periods, and mitigate complications. Concurrently, there is an increasing incidence of peripheral nerve injuries, driven by factors like sports-related trauma, accidents, and an aging population, expanding the patient base in need of effective treatments. Additionally, personalized medicine is gaining traction, tailoring treatments based on injury type, severity, patient demographics, and health status, promising improved efficacy and minimized adverse effects.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Peripheral Nerve Injuries Market by Injury Type

• Market Overview
• Traumatic Injuries
• Compression Injuries
• Surgical Injuries

Peripheral Nerve Injuries Market by Product

• Market Overview
• Nerve Conduit
• Nerve Protector
• Nerve Connector
• Nerve Wraps

Peripheral Nerve Injuries Market by Treatment

• Market Overview
• Surgical Interventions
• Physical Therapy
• Pharmaceutical Interventions

Peripheral Nerve Injuries Market by Surgery

• Market Overview
• Direct Nerve Repair
• Nerve Grafting
• Stem Cell Therapy

Peripheral Nerve Injuries Market by Application

• Market Overview
• Lower Extremities
• Upper Extremities

Peripheral Nerve Injuries Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axogen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoPediatrics Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AxoGen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments